A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinosarcoma
  • Epothilones
  • Neoplasm Recurrence, Local
  • Uterine Neoplasms

abstract

  • In this cohort of women, single agent ixabepilone showed modest but insufficient clinical activity.

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5362250

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2016.10.026

PubMed ID

  • 28029447

Additional Document Info

start page

  • 101

end page

  • 106

volume

  • 144

number

  • 1